Energy balance
Pharmacological activation of brown and beige adipose tissue thermogenesis via beta-3 adrenergic signaling or UCP1-independent futile cycles increases energy expenditure and improves systemic metabolic health.
Your fat tissue is not just storage; it actively regulates your metabolism. While cold exposure can activate brown fat, current medical strategies focus on pharmacological agents (like GLP-1 agonists) that may indirectly support metabolic health. Understanding that visceral fat is metabolically harmful while subcutaneous fat is more neutral can guide lifestyle choices, but surgical removal of fat is not a cure for metabolic disease.
Thermogenic adipocytes increase energy expenditure via mitochondrial uncoupling or adenosine triphosphate-consuming futile substrate cycles, while functioning as a metabolic sink and participating in crosstalk with other metabolic organs. Manipulation of adipose tissue provides a wealth of opportunities to intervene and combat the progression of associated metabolic diseases.
Why this rating
The paper is a comprehensive review citing extensive human and animal studies, though it notes some conflicting results regarding specific mechanisms.
Source
Adipose Tissue and Metabolic Health
Sung‐Min An et al. · Diabetes & Metabolism Journal · 2023
DOI 10.4093/dmj.2023.0011
More from this paper
- GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists improve metabolic health in obesity and type 2 diabetes by lowering BMI, improving insulin sensitivity, and potentially activating thermogenic fat.Strong
- Visceral adipose tissue accumulation is a primary risk factor for cardiometabolic disease, whereas subcutaneous fat is metabolically neutral or healthy.Strong
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →